As of 2025-09-16, the Fair Value of Tissue Regenix Group PLC (TRX.L) is -21.63 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 25.50 GBP, the upside of Tissue Regenix Group PLC is -184.82%.
With the market price of 25.50 GBP and our fair value calculation, Tissue Regenix Group PLC (TRX.L) is not a good investment. Investing in TRX.L stocks now will result in a potential loss of 184.82%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -11.98 | -4.79 | -2.69 | -1.71 | -0.71 | -4.38 |
| YoY growth | -40.01% | 60.02% | 43.76% | 36.44% | 58.38% | 31.72% |
| Market Cap (mil) | 21.01 |
| P/E | |
| Forward P/E | 108.68x |
| EPS | -0.87 |
| Avg earnings growth rate | 31.72% |
| TTM earnings | -0.71 |